Vascular cognitive impairment.
Bowler
J V
JV
Department of Neurology, Royal Free Hospital, London, UK. j.bowler@rfc.ucl.ac.uk
D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000150:complications*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology* / Q000517:prevention & control; D015140:Dementia, Vascular / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D015259:Dopamine Agents / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008559:Memantine / Q000627:therapeutic use; D009483:Neuropsychological Tests / Q000706:statistics & numerical data; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D055502:Secondary Prevention; D020521:Stroke / Q000517:prevention & control; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D002800:Cholinesterase Inhibitors; D015259:Dopamine Agents; D008559:Memantine